Cytokinetics Inc
CYTK
$66.16+2.32%
End of day · as of Sep 28, 2026, 4:37 PM ET
Mkt cap
$4.05B
EV/Sales
47.9
P/E ratio
N/A
FY2025 Revenue
$88.04M
EPS (TTM)
$-7.22
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-891.60%
Beta
0.59
Div yield
N/A
Sector
Healthcare
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Latest reported CYTK revenue for 2025-12-31 was $88.0M. Net income was -$785.0M. Revenue was up 376.6% from 2024-12-31 to 2025-12-31. CYTK currently screens at market cap $4.05B.
Use this CYTK research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CYTK income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Cytokinetics Inc (CYTK) is a biotechnology company in the Healthcare sector.
Latest cached Cytokinetics Inc (CYTK) revenue for Dec 31, 2025 was $88.0M. Net income was -$785.0M. Statements: https://lician.com/financials/cytk
Cytokinetics Inc (CYTK) market capitalization is $4.05B on the latest cached snapshot.
Cytokinetics Inc (CYTK) cached previous close $64.66; day range $64.25 – $66.41; volume 2,550,057. Session quote: https://lician.com/quote/cytk
Cytokinetics Inc (CYTK) latest cached earnings event is "CYTK earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CYTK filing is 8-K · Aug 28, 2026. Filings: https://lician.com/sec/cytk